PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

38,389 stories, page 264 of 640

Advanced search
🌍discoverynews.google.comTier 3 · Aggregated media

Massachusetts Biotech's Flagship Gene Therapy Posts Fifth Straight Quarterly Decline as Muscular Dystrophy Data Loom

Streetwise ReportsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Zacks.com featured highlights include BioMarin Pharmaceutical, Invesco, Centene Corporation, Hewlett Packard Enterprise and Gibraltar Industries

Yahoo FinanceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

National priority vouchers: a year of reform?

The Pharma LetterOriginal source
🌍Researchpnas.orgTier 2 · Direct publisher

Probes show lipids are far more selective for proteins than once thought

PNASOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Parliament calls for pause to controversial directive amid fears of drug shortages and huge industry bill

medwatch.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Pace appoints Andy Fenny as president to drive life science growth

The Pharma LetterOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Citizens raises Sagimet stock price target to $29 on acne drug

Investing.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

EMA takes Pfizer and Valneva Lyme disease vaccine into review

The Pharma LetterOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Zealand Pharma sells rusfertide royalties for $100 million

The Pharma LetterOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Measles, mumps, rubella and varicella (MMRV) vaccination programme

Documents relating to the measles, mumps, rubella and varicella (MMRV) vaccination programme.

UK Health Security AgencyOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Meningococcal B (MenB) time limited vaccination offer

Documents relating to the time-limited MenB vaccination offer for Year 13 age group for 2025/2026 an...

UK Health Security AgencyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

SLS Stock Kicks Off Week In Green: CEO Flags Role In EU Biotech Policy Talks That Could Impact Drug Approvals

StocktwitsOriginal source
🌍discoverynews.google.comTier 2 · Trade media

MapLight dims preclinical programs to make phase 3-ready schizophrenia drug shine brighter

Fierce BiotechOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Biotech Stocks At 52-Week Highs - PARK +10%, AVAH +24%, CADL +10% On Q2 Reports, LH, COAG

RTTNewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Former Bridge Biotherapeutics CEO Lee resurfaces in biotech after BBT-877 fallout

koreabiomed.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Chenguang Biotech Warned Over Rule Violations

tradingview.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Ascendis Pharma doubles sales, significantly boosting profit

medwatch.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA crackdown puts major food chains under scanner over safety lapses

Mid-DayOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Weekly all-cause mortality surveillance: week ending 16 August 2026

How the actual number of deaths in England compare with expected numbers for each week.

UK Health Security AgencyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Former Bridge Biotherapeutics CEO Lee resurfaces in biotech after BBT-877 fallout

koreabiomed.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Zipalertinib Plus Chemotherapy Meets Primary Endpoint in Phase 3 EGFR Exon 20 Trial

clinicaltrialvanguard.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Ultragenyx Pharmaceutical Inc. Stock 12‑Month Price Target Cut to $52, Implies 97% Upside

tradingview.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Greenlit by the FDA, yet too cheap to stay? Korea’s penny stock rule puts biotech firms on edge.

Korea JoongAng DailyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Once intended for Seagen, Dermody sells empty biotech plant for $78M

DJCOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

The compliance burden nobody talks about

Manufacturing ChemistOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Zealand Pharma CEO urges patience after delayed start of clinical trial

medwatch.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Nektar Raises Cash to Fund Rezpegaldesleukin Phase 3 Trials Through 2028

clinicaltrialvanguard.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

IFC Invests in Mexico Pharmaceutical Manufacturing to Strengthen Medicine Supply Chains

fundsforNGOs NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Clears Denifanstat Phase 3 Trial for Moderate to Severe Acne

clinicaltrialvanguard.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Industrial-Scale Biotech Production Of Proteins And Vitamins Economically Viable | Newswise

NewswiseOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

RTW Biotech Opportunities Outperforms Biotech Benchmarks In July

DirectorsTalk InterviewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

REG - RTW Biotech Opp. - Monthly Valuation Update and Factsheet

tradingview.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Dongkook Pharmaceutical boosts H1 profit as dermacosmetics surge overseas - CHOSUNBIZ

ChosunbizOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Seattle biotech InduPro raises $77 million to advance cancer treatment pipeline

The Business JournalsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

How Changes at the FDA Could Reshape Drug Approval and Safety

The FulcrumOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Burning Rock Biotech (NASDAQ:BNR) Stock Price Down 3.7% - What's Next?

MarketBeatOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

(08/14/26) ACHV: A Speculative Trade in the Biotech Sector

moneyshow.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Food, Drug Licence Scam Alert: Maharashtra FDA Flags Fake Agents Demanding Money

NDTV ProfitOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Bengaluru Startup Dognosis Uses AI and Dogs for Cancer Screening

WhalesbookOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Celltrion Vegzelma Matches Original Drug in Study

BusinesskoreaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Six Bengaluru hotels fined Rs 1.6L for food safety breach

The New Indian ExpressOriginal source
🌍discoverynews.google.comTier 2 · Trade media

PhenoNet Cleared by FDA to Begin Phase 3 Trial of Inhaled PHENOGENE-1A in Early Alzheimer's Disease

BioSpaceOriginal source
🌍discoverynews.google.comTier 2 · Trade media

JW Pharmaceutical Proves Efficacy of Key 6mg Dose of Gout Treatment ‘Epaminurad’ in Multinational Phase 3 Trial

BioSpaceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA crackdown puts major food chains under scanner over safety lapses

Mid-DayOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Paradigm Biopharmaceuticals (ASX:PAR): Zilosul Phase 3 Trial Moves Towards Key Data Readout

KalkineOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Recce Pharmaceuticals (ASX:RCE): R327G Diabetic Foot Infection Trial Advances to Phase 3

KalkineOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Richard Sullivan: China’s Pharmaceutical Rise Signals a New Global Power Shift

OncodailyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

CADL Rises As Biotech Eyes First Commercial Product in 2027 — CEO Points To ‘Meaningful Execution’ Toward BLA Submission In Q4

StocktwitsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Celltrion's Vegzelma Integrated Phase 1 and 3 Analysis Published in International Journal

asiae.co.krOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

RTW Biotech Opportunities Ltd USD Revenue Breakdown – GETTEX:0BM

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Edesa Biotech (NASDAQ:EDSA) Posts Earnings Results, Misses Expectations By $0.16 EPS

MarketBeatOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Fortress Biotech earnings beat by $0.11, revenue fell short of estimates

Investing.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Fortress Biotech (NASDAQ:FBIO) Posts Earnings Results, Beats Estimates By $0.12 EPS

MarketBeatOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Phase 3 Trials Report Upadacitinib’s Efficacy in Severe Alopecia Areata

Physician's WeeklyOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

National Institute on Alcohol Abuse and Alcoholism; Notice of Partially Closed Meeting

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Determination That ANSAID (Flurbiprofen) Tablets, 50 Milligrams and 100 Milligrams, Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness

The Food and Drug Administration (FDA, Agency, or we) has determined that ANSAID (flurbiprofen) tabl...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Exempt Chemical Preparations Under the Controlled Substances Act

The applications for exempt chemical preparations received by the Drug Enforcement Administration be...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Notice of Award of a Single Source Cooperative Agreement To Fund International Rescue Committee

The Centers for Disease Control and Prevention (CDC), located within the Department of Health and Hu...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Reauthorization of the Prescription Drug User Fee Act; Public Meeting; Request for Comments

The Food and Drug Administration (FDA, the Agency, or we) is hosting a public meeting to discuss pro...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Determination That LASIX (Furosemide) Tablets, 20 Milligrams, 40 Milligrams, and 80 Milligrams, Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness

The Food and Drug Administration (FDA, Agency, or we) has determined that LASIX (furosemide) tablets...

Federal RegisterOriginal source